Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
Notified -
Globe NewswireYesterday, 15:40
VCI Global Appoints Victor Lee as Executive Director 21-10-2024, 19:31